It's something our bodies make on their own, but like many good things, our natural supply dwindles as we get older
Directed human clinical trials are necessary to validate BPC-157's efficacy in musculoskeletal injury, gastrointestinal, and vascular disorders that show promise in preclinical models
Nevertheless, if its senolytic action has been demonstrated in several diseases such as osteoarthritis 15,16 as well as in neurodegenerative diseases 17 , the effect of ABT-263 is restricted to senescent cells from specific cell types 18 , leading to the necessity to identify new potential senolytics to target senescent cells in age-related diseases
Common side effects are typically mild and temporary: Injection site reactions (redness, slight bruising) Mild headaches (usually first week only) Temporary fatigue as your body adjusts Serious side effects are rare when protocols are followed correctly
A single peptide addresses one or two aspects of a complex goal